The report studies the global guidewires market over the forecast period of 2017 to 2022. The market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=8118028

The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries.

Factors such as high cost of surgical guidewires, spending cuts, and excise duties on medical devices and dearth of skilled surgeons for minimally invasive surgeries are expected to restrain the growth of the market during the forecast period.

Some of the major players in the market are Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US).

Stakeholders

• Original equipment manufacturers (OEMs)
• Product sales and distribution companies
• Healthcare service providers (such as hospitals, diagnostic, and surgical centers)
• Non-government organizations
• Government regulatory authorities
• Research laboratories and academic institutes
• Clinical research organizations (CROs)
• Research and development companies
• Market research and consulting firms

This report covers the market across four major regions. North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for guidewires among developed countries, increasing patient preference for minimally invasive surgical procedures (including atherectomy, thrombectomy, embolectomy, and gastrointestinal endoscopy), and strong market presence of key OEMs (that replicates into easy availability of guidewires) are driving the growth of the North American guidewires market.

Read More @ https://www.marketsandmarkets.com/PressReleases/guidewire.asp